• Spotlight: Pipeline of Swiss Biotech Industry
• Biotechgate brings you more companies and features
• BIO 2011: See you in Washington
• New partnerships increase data quality
• Investment opportunities in Medicon Valley
• Meet us at upcoming conferences

The pipeline of Swiss Biotech companies are filled quite well. Currently there are over 130 products in pre-clinical development. In clinical development, Swiss companies have over 40 products in phase I as well as almost 50 in phase II. These numbers are now back above the level before the financial crisis 2008. However, the analysis also shows that many companies had difficulties moving products from the pre-clinical stage into the clinic due to lack of sufficient capital.

If you would like to be able to do such analysis by yourself and for any country, please have a close look at Biotechgate.com.

Biotechgate has launched a new version of its Global Biotechgate Database with new search features and state-of the art usability. At the same time the database has reached over 20’000 company profiles. The database provides different levels of access, from a free subscription to monthly and annual subscriptions starting at EUR 125 per month.

Read more

Venture Valuation will be present at BIO in Washington at the Swiss booth no. 5023. Come and have a look at our Biotechgate database or get some information how you can properly valuate your company or product. Joining us at the Swiss booth will be numerous interesting Swiss companies including AC Immune, BioAlps, BioArk SA Biopôle SA, Debiopharm S.A., ExcellGene, Harlan Laboratories Ltd., Life Science Zurich, Lonza Group Ltd. , Med Discovery SA, Molecular Partners AG, regulanet Schweiz, SIX Swiss Exchange, Swissaustral Biotech SA, Swiss Biotech Association, Switzerland. Trade & Investment Promotion and TRB Chemedica International SA.

With the addition of new partners, such as One Nucleus in the UK, APIM - the Lille Metropole Development Agency and Assobiotec - the Italian Association for the Development of Biotechnology, Biotechgate will continue to strive to deliver the most current up to date and complete life science company and licensing deal information.

Read more

Medicon Valley, one of the Global Partners of Biotechgate, offers a variety of business and investment opportunities covering Eastern Denmark and Southern Sweden and is home to one of Europe's strongest and most renowned life science clusters.
Learn more about your business opportunities in Medicon Valley here.

For more information please contact

• Business Development Manager Vibeke Dalhoff, vda@copcap.com (Eastern Denmark)
• Business Developer Lovisa Sunesson, lovisa.sunesson@skane.com (Southern Sweden)